Source:http://linkedlifedata.com/resource/pubmed/id/11423483
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2001-6-25
|
pubmed:abstractText |
The reason for the 3- to 4-h delay between a rise in plasma free fatty acid (FFA) levels and the development of insulin resistance remains unknown. In the current study, we have tested the hypothesis that the delay may be caused by the need for plasma FFAs to first enter muscle cells and to be re-esterified there before causing insulin resistance. To this end, we have determined intramyocellular triglyceride (IMCL-TG) content with proton nuclear magnetic resonance ((1)H-NMR) spectroscopy in healthy volunteers before and 4 h after lowering of plasma FFAs (with euglycemic-hyperinsulinemic clamping) or after increasing plasma FFAs (with lipid plus heparin infusions). Increasing plasma FFAs (from 516 to 1,207 micromol/l or from 464 to 1,857 micromol/l, respectively) was associated with acute increases in IMCL-TG from 100 to 109 +/- 5% (P < 0.05) or to 133 +/- 11% (P < 0.01), respectively, and with a significant increase in insulin resistance (P < 0.05 after 3.5 h). Lowering of plasma FFAs from 560 to 41 micromol/l was associated with a tendency for IMCL-TG to decrease (from 100 to 95 +/- 3%). Changes in plasma FFAs correlated linearly with IMCL-TG (r = 0.74, P < 0.003). The demonstration that acute changes in plasma FFAs were accompanied by corresponding changes in IMCL-TG and with the development of insulin resistance, taken together with previous reports of a close correlation between IMCL-TG and insulin resistance, supported the notion that accumulation of IMCL-TG is a step in the development of FFA-induced insulin resistance.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0012-1797
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1612-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11423483-Adipose Tissue,
pubmed-meshheading:11423483-Adult,
pubmed-meshheading:11423483-Blood Glucose,
pubmed-meshheading:11423483-Body Composition,
pubmed-meshheading:11423483-Calorimetry, Indirect,
pubmed-meshheading:11423483-Fatty Acids, Nonesterified,
pubmed-meshheading:11423483-Female,
pubmed-meshheading:11423483-Humans,
pubmed-meshheading:11423483-Insulin,
pubmed-meshheading:11423483-Insulin Resistance,
pubmed-meshheading:11423483-Magnetic Resonance Spectroscopy,
pubmed-meshheading:11423483-Male,
pubmed-meshheading:11423483-Muscles,
pubmed-meshheading:11423483-Oxidation-Reduction,
pubmed-meshheading:11423483-Reference Values,
pubmed-meshheading:11423483-Triglycerides
|
pubmed:year |
2001
|
pubmed:articleTitle |
Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects.
|
pubmed:affiliation |
Division of Endocrinology/Diabetes/Metabolism, General Clinical Research Center, Temple University School of Medicine, 3401 North Broad Street, Philadelphia, PA 19140, USA. bodengh@tuhs.temple.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|